Home/Filings/4/0001661539-23-000008
4//SEC Filing

Trevejo Jose M. 4

Accession 0001661539-23-000008

CIK 0001819790other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 5:32 PM ET

Size

4.8 KB

Accession

0001661539-23-000008

Insider Transaction Report

Form 4
Period: 2023-12-20
Trevejo Jose M.
CHIEF MEDICAL OFFICER
Transactions
  • Sale

    Common Stock

    2023-12-20$20.00/sh2,252$45,0402,251 total
Footnotes (1)
  • [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2023.

Issuer

Tarsus Pharmaceuticals, Inc.

CIK 0001819790

Entity typeother

Related Parties

1
  • filerCIK 0001661539

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:32 PM ET
Size
4.8 KB